Cargando…
Mega Hpv laboratories for cervical cancer control: Challenges and recommendations from a case study of Turkey
Cervical cancer is the fourth most common cancer among women in the world. It is estimated that one woman dies every 2 min from cervical cancer. Nearly all cervical cancers are preventable by early detection and treatment through screening or HPV vaccination. In 2018, World Health Organization (WHO)...
Autores principales: | Gultekin, Murat, Karaca, Mujdegul Zayifoglu, Kucukyildiz, Irem, Dundar, Selin, Keskinkilic, Bekir, Turkyilmaz, Murat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426700/ https://www.ncbi.nlm.nih.gov/pubmed/30878532 http://dx.doi.org/10.1016/j.pvr.2019.03.002 |
Ejemplares similares
-
Survival of gynecological cancers in Turkey: where are we at?
por: Gultekin, Murat, et al.
Publicado: (2017) -
Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women
por: Gultekin, Murat, et al.
Publicado: (2017) -
Centralization of mammography reporting with mobile trucks: Turkish experience
por: Gultekin, Murat, et al.
Publicado: (2018) -
Does drug compliance change in asthmatic patients during pregnancy?
por: Yilmaz, Insu, et al.
Publicado: (2013) -
Sociodemographic and clinical features of postpartum depression among Turkish women: a prospective study
por: Turkcapar, Ayse Figen, et al.
Publicado: (2015)